Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 Injection for Radiotherapy-Associated Pain in Colorectal and Rectal Cancer
NCT06209970Completed
- Sponsor
- Nakhia Impex LLC
- Start
- Dec 2023
- Primary completion
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in cancer pain, sponsored by Nakhia Impex LLC. Primary endpoint: Numerical Rating Scale at 72 hours. Started Dec 2023; status: completed.
02
Drugs
ha35
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT06209970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209970.